Wu Xiaoxia,Liu Wenyue,Sun Xue,et al.Risk factors and prognosis of recurrent cholangitis after Kasai in biliary atresia patients[J].Journal of Clinical Pediatric Surgery,,22():244-248.[doi:10.3760/cma.j.cn101785-202212005-008]
Risk factors and prognosis of recurrent cholangitis after Kasai in biliary atresia patients
- Keywords:
- Biliary Atresia; Cholangitis; Prognosis; Root Cause Analysis
- Abstract:
- Objective To explore the risk factors and outcomes of recurrent cholangitis after Kasai in biliary atresia (BA) patients.Methods Retrospective review was conducted for clinical and follow-up data of 60 BA children with cholangitis after Kasai procedure from January 2018 to September 2021.According to whether the frequency of cholangitis episodes was more than or equal to 3 times in half a year,they were divided into two groups of recurrent cholangitis (n=20) and occasional cholangitis (n=40).Gender,preoperative body mass index (BMI),cytomegalovirus (CMV) infection,age at Kasai surgery,liver fibrosis grade,serum levels of liver function parameters at preoperation and Day 14 postoperation and the occurrence of early cholangitis were compared between two groups.Cox regression analysis was performed for estimating the risk factors of recurrent cholangitis.Postoperative jaundice clearance (JC) rate and postoperative native liver survival rate were also compared between two groups.Results No significant differences existed in gender,preoperative BMI,CMV infection,age at Kasai or liver fibrosis grade (P>0.05).Serum total bile acid level at preoperation was significantly lower in recurrent cholangitis group than that in occasional cholangitis group (Z=-2.070,P<0.05).Alanine transaminase(ALT)[(169.47±93.53)U/L],Aspartate trans aminase(AST)[(173.96±96.25)U/L],[242.50(169.68,296.13)ratio 244.50(148.50,297.00)U/L],gamma-glutamyl transferase(GGT)[572.00(310.75,895.75)than 388.00(245.50,695.25)U/L],total bilirubin,(219.61±73.08)ratio(207.38±58.63)μmol/L),direct bilirubin(DBIL)ratio(122.70(104.50,163.25)ratio 116.70(81.42,158.35)μmol/L］and albumin,Alb[(36.27±2.91)vs.(37.88±4.90)g/L]at preoperation between 2 groups had no significant difference(P>0.05).ALT[(211.23±144.87)to(229.87±104.76)U/L]and AST[162.50(108.17,225.75)to 196.50(160.75,235.43)U/L],GGT[(742.85±438.09)vs.(584.05±385.31)U/L],TBIL[136.20(86.05,190.23)vs.145.50(95.73,213.90)μmol/L],DBIL[79.85(60.88,122.83)vs.90.00(61.30,129.30)μmol/L]and Alb[(37.92±5.55)vs.(39.22±4.55)g/L]at day 14 postoperation between 2 groups were not significantly different(P>0.05).The incidence of early cholangitis was significantly higher in recurrent cholangitis group than that in occasional cholangitis group (χ2=9.909,P<0.05).Cox regression analysis revealed that early cholangitis was risk factor for recurrent cholangitis; JC rate of recurrent cholangitis group was lower than that of occasional cholangitis group at Month 3/6 postoperation.However,the difference was not statistically significant (P>0.05).JC rate at Month 12 postoperation was significantly lower in recurrent cholangitis group than that in occasional cholangitis group (χ2=5.179,P<0.05).No significant inter-group difference existed in native liver survival rate at 1 year postoperation (P>0.05).Conclusion Early cholangitis is an independent risk factor for recurrent cholangitis after Kasai in BA children.And recurrent cholangitis affects the postoperative jaundice clearance.
References:
[1] Kasahara M,Umeshita K,Sakamoto S,et al.Liver transplantation for biliary atresia:a systematic review[J].Pediatr Surg Int,2017,33(12):1289-1295.DOI:10.1007/s00383-017-4173-5.
[2] Ramos-Gonzalez G,Elisofon S,Dee EC,et al.Predictors of need for liver transplantation in children undergoing hepatoportoenterostomy for biliary atresia[J].J Pediatr Surg,2019,54(6):1127-1131.DOI:10.1016/j.jpedsurg.2019.02.051.
[3] de Ville de Goyet J,Illhardt T,Chardot C,et al.Variability of care and access to transplantation for children with biliary atresia who need a liver replacement[J].J Clin Med,2022,11(8):2142.DOI:10.3390/jcm11082142.
[4] Chen SY,Lin CC,Tsan YT,et al.Number of cholangitis episodes as a prognostic marker to predict timing of liver transplantation in biliary atresia patients after Kasai portoenterostomy[J].BMC Pediatr,2018,18(1):119.DOI:10.1186/s12887-018-1074-2.
[5] Lee JY,Lim LTK,Quak SH,et al.Cholangitis in children with biliary atresia:health-care resource utilisation[J].J Paediatr Child Health,2014,50(3):196-201.DOI:10.1111/jpc.12463.
[6] Liu J,Dong R,Chen G,et al.Risk factors and prognostic effects of cholangitis after Kasai procedure in biliary atresia patients:a retrospective clinical study[J].J Pediatr Surg,2019,54(12):2559-2564.DOI:10.1016/j.jpedsurg.2019.08.026.
[7] 葛亮,詹江华,高伟,等.胆道闭锁Kasai术后早期行肝移植手术的危险因素分析[J].天津医药,2019,47(4):351-355.DOI:10.11958/20190343. Ge L,Zhan JH,Gao W,et al.Risk factors of early liver transplantation after Kasai procedure for biliary atresia[J].Tianjin Med J,2019,47(4):351-355.DOI:10.11958/20190343.
[8] Chung PHY,Wong KKY,Tam PKH.Predictors for failure after Kasai operation[J].J Pediatr Surg,2015,50(2):293-296.DOI:10.1016/j.jpedsurg.2014.11.015.
[9] 郭鑫,孙雪,任红霞.102例胆道闭锁Kasai术后胆管炎分析[J].临床小儿外科杂志,2017,16(2):146-150.DOI:10.3969/j.issn.1671-6353.2017.02.010. Guo X,Sun X,Ren HX.Analysis of cholangitis in patients with biliary atresia after Kasai operation[J].J Clin Ped Sur,2017,16(2):146-150.DOI:10.3969/j.issn.1671-6353.2017.02.010.
[10] 中华医学会小儿外科学分会肝胆外科学组.胆道闭锁Kasai术后胆管炎诊疗专家共识(2022版)[J].中华小儿外科杂志,2022,43(9):769-774.DOI:10.3760/cma.j.cn421158-20220427-00308. Group of Pediatric Hepatobiliary Surgery,Society of Pediatric Surgery,Chinese Medical Association:Expert Consensus on Diagnosing&Treating Cholangitis after Kasai Operation for Biliary Atresia (2022 Edition)[J].Chin J Pediatr Surg,2022,43(9):769-774.DOI:10.3760/cma.j.cn421158-20220427-00308.
[11] Chen G,Liu J,Huang YL,et al.Preventive effect of prophylactic intravenous antibiotics against cholangitis in biliary atresia:a randomized controlled trial[J].Pediatr Surg Int,2021,37(8):1089-1097.DOI:10.1007/s00383-021-04916-z.
[12] Jiang H,Gao PF,Chen HD,et al.The prognostic value of CD8+and CD45RO+T cells infiltration and beclin1 expression levels for early postoperative cholangitis of biliary atresia patients after Kasai operation[J].J Korean Med Sci,2018,33(30):e198.DOI:10.3346/jkms.2018.33.e198.
[13] 葛亮,苟庆云,赵金凤,等.肝脏CD4、CD8及CD68表达与Kasai术后胆管炎的关系研究[J].天津医药,2020,48(8):720-725.DOI 10.11958/20192986. Ge L,Gou QY,Zhao JF,et al.Relationship between expressions of CD4,CD8 and CD68 in liver and cholangitis after Kasai operation[J].Tianjin Med J,2020,48(8):720-725.DOI:10.11958/20192986.
[14] Harpavat S,Hawthorne K,Setchell KDR,et al.Serum bile acids as a prognostic biomarker in biliary atresia following Kasai portoenterostomy[J/OL].Hepatology,2022.DOI:10.1002/hep.32800.
[15] Karpen SJ,Kelly D,Mack C,et al.Ileal bile acid transporter inhibition as an anticholestatic therapeutic target in biliary atresia and other cholestatic disorders[J].Hepatol Int,2020,14(5):677-689.DOI:10.1007/s12072-020-10070-w.
[16] Chusilp S,Sookpotarom P,Tepmalai K,et al.Prognostic values of serum bilirubin at 7th day post-Kasai for survival with native livers in patients with biliary atresia[J].Pediatr Surg Int,2016,32(10):927-931.DOI:10.1007/s00383-016-3951-9.
[17] Wang ZM,Chen YJ,Peng CH,et al.Five-year native liver survival analysis in biliary atresia from a single large Chinese center:the death/liver transplantation hazard change and the importance of rapid early clearance of jaundice[J].J Pediatr Surg,2019,54(8):1680-1685.DOI:10.1016/j.jpedsurg.2018.09.025.
[18] Nightingale S,Stormon MO,O’Loughlin EV,et al.Early posthepatoportoenterostomy predictors of native liver survival in biliary atresia[J].J Pediatr Gastroenterol Nutr,2017,64(2):203-209.DOI:10.1097/MPG.0000000000001289.
Memo
收稿日期:2022-12-3。
基金项目:山西省卫生健康委课题(2022074),山西省儿童医院院内课题(2021027)
通讯作者:任红霞,Email:renhongxia100@sina.com